Total planned funding: $120,557,804
Allocations
Countries/Regions
Ukraine | $120,557,804 |
Organizational Types
Unknown | $33,942,913 |
Private Contractor | $27,778,578 |
NGO | $20,688,965 |
Own Agency | $13,969,668 |
Multi-lateral Agency | $10,788,586 |
University | $6,100,000 |
Other USG Agency | $4,589,094 |
Implementing Agency | $2,700,000 |
Program Areas
Governance and Systems | $52,301,260 |
Treatment | $25,447,965 |
Testing | $15,734,626 |
Prevention | $10,070,546 |
Management and Operations | $9,366,228 |
Care | $7,637,179 |
Budget Codes
OHSS: Health Systems Strengthening | $30,768,823 |
HVCT: Testing: HIV Testing and Counseling | $15,734,626 |
HTXS: Treatment: Adult Treatment | $13,042,675 |
HVSI: Strategic Information | $12,495,438 |
HTXD: Treatment: ARV Drugs | $12,405,290 |
HVMS: Management and Operations | $9,366,228 |
HLAB: Laboratory Infrastructure | $9,036,999 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $4,796,703 |
HVTB: Care: TB/HIV | $3,734,440 |
HVOP: Sexual Prevention: Other Sexual Prevention | $2,905,154 |
HBHC: Care: Adult Care and Support | $2,163,611 |
HMBL: Biomedical Prevention: Blood Safety | $1,942,932 |
HKID: Care: Orphans and Vulnerable Children | $1,739,128 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $293,357 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $132,400 |
HMIN: Biomedical Prevention: Injection Safety | $0 |
Top Partner Programs
Not Available:
$30,172,913
Countries/Regions
Chemonics International:
$16,839,470
Countries/Regions
Deloitte Consulting Limited:
$10,239,108
Countries/Regions
USG Aggregated Agencies:
$8,936,932
Countries/Regions